The Role of Real-World Evidence in UK Reimbursement: Case Study of Lenalidomide in Myelodysplastic Syndrome Deletion 5q

BACKGROUND: Uncertainty within cost-effectiveness analysis, often driven by lack of mature data from large clinical trials, plays a key role in decisions made by the National Institute for Health and Care Excellence (NICE), particularly for early access medicines and orphan drugs. OBJECTIVES: In thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Dawn, Brereton, Nic, Dhanasiri, Sujith, Kulasekararaj, Austin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710314/
https://www.ncbi.nlm.nih.gov/pubmed/30552652
http://dx.doi.org/10.1007/s41669-018-0110-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710314/
https://www.ncbi.nlm.nih.gov/pubmed/30552652
http://dx.doi.org/10.1007/s41669-018-0110-3

Ejemplares similares